期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY LetPub Score 7.5
50 ratings
Rate
Reputation 8.7 Influence 6.7 Speed 6.9 | ||||||||||||||||||||||||
期刊簡稱 | CRIT REV ONCOL HEMAT | ||||||||||||||||||||||||
ISSN | 1040-8428 | ||||||||||||||||||||||||
E-ISSN | 1879-0461 | ||||||||||||||||||||||||
h-index | 111 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 1.80%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.croh-online.com/ | ||||||||||||||||||||||||
在線稿件提交 | http://ees.elsevier.com/croh | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier Ireland Ltd | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1983 | ||||||||||||||||||||||||
每年文章數 | 264每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 29.21% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) 來自Elsevier的數據: Average 27.3 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary 來自Elsevier的數據: 83% | ||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 8.8 Week(s) | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 | |
[CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY] 的評論 | 撰寫評論 |
作者: 刘昕澜 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-31 09:22:31 評論於 May I ask about the follow-up results? Has the status changed? I have been waiting for nearly a month now, and I have emailed both the chief editor and the editors, but there has been no response. ![]() ![]() |
作者: 11jj 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-08-23 09:54:15 評論於 I submitted on July 26th, and the whole process was very fast. If it takes two months, you can follow up to push for the manuscript. I previously submitted to an Elsevier journal and the external review took a long time. I contacted Elsevier's customer service to help me push the editor, and a few days later it was decided. ![]() ![]() |
作者: recept 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-23 09:47:03 評論於 Hello, how is everything going? ![]() ![]() |
作者: recept 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-23 09:45:33 評論於 Just saw the submission time on another post. In this case, can we ask the editor to hurry up the submission? ![]() ![]() |
作者: recept 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-23 09:37:49 評論於 Hello, I would like to know when you submitted your application? It has been two months and I have not received any updates, my messages are not being replied to. ![]() ![]() |
作者: 11jj 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-08-22 21:57:53 評論於 Six people reviewed the manuscript in the first round, but when two of them came back with their opinions, the editors decided to make major revisions, causing a delay that lasted for a day. ![]() ![]() |
作者: 施景龙 SHI 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-20 23:41:39 評論於 May I ask how many people are reviewing the first round, and have you experienced a dip before? ![]() ![]() |
作者: 11jj 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-08-19 14:13:01 評論於 Immunotherapy for tumors. ![]() ![]() |
作者: 刘昕澜 領域: 医学 審稿時間: 2.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-15 23:50:01 評論於 Hello! May I ask which sector's overview did you invest in? ![]() ![]() |
作者: 施景龙 SHI 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-15 19:19:36 評論於 What direction are you writing in? Is it a summary? ![]() ![]() |
作者: 施景龙 SHI 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-15 19:18:15 評論於 What direction are you writing in? Can I ask? ![]() ![]() |
作者: 11jj 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-08-14 15:03:18 評論於 A very pleasant submission experience. The first time encountering such a fast process (unbelievable) 7.26 Submit to the journal 7.29 With editor 7.29 Under Review 8.1 RRC 8.1 Major revision 8.5 Revision submit 8.7 RRC 8.7 Accept 8.8 Online ![]() ![]() |
作者: recept 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-08-11 08:45:29 評論於 The speed is too slow, it has been over a month and I have sent three letters but received no response. ![]() ![]() |
作者: 吡啡尼酮 領域: 医学 審稿時間: 12.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-01-02 13:45:41 評論於 With editor for 2 months, under review for 6 months, still unable to find reviewers. Major revisions at 9 months. Accepted after minor revisions at 11 months. Please consider carefully if urgent. ![]() ![]() |
作者: 鑫钰baby 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-15 15:21:18 評論於 Research focus: tumors; sharing experiences with solid tumors: Where did the magazine editor go? No news for two months with the editor. ![]() ![]() |
作者: 碧水傲文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-28 10:41:04 評論於 How did you find the email address of the editor-in-chief? ![]() ![]() |
作者: 无妄迎真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-25 13:17:22 評論於 Is there any news now? ![]() ![]() |
作者: 百花梦竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-29 14:11:11 評論於 Focused research direction: tumor experience sharing: Submitted on December 15th, still with editor ![]() ![]() |
作者: MW小白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-23 12:48:05 評論於 Submitted on 21st November 2023, still "with editor" as of 23rd January 2024. No response received from editor after sending withdrawal email. It is recommended not to submit to this journal ![]() ![]() |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-17 23:44:38 評論於 Review speed: 3.0 Research focus: Review articles Experience sharing in hematologic tumors: with editor My submission has been in the "with editor" status for two and a half months, and then it was rejected directly, wasting three months of my time. Please be cautious when submitting ![]() ![]() |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-12 18:43:37 評論於 I have reminded three times already ![]() ![]() |
作者: 南川怀南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-02 14:38:24 評論於 Is there any news now? I would like to have a reference ![]() ![]() |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-16 16:24:03 評論於 Heavy research direction: Overview; Blood cancer experience sharing: with editor for one month, two reminders, still no news, frustrating ![]() ![]() |
作者: 南川怀南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-12 19:38:23 評論於 Is there any follow-up to this? I would like to reference it, thank you ![]() ![]() |
作者: 法慧若曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-10 13:46:01 評論於 On the second day ![]() ![]() |
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 |
Contact us